Busca avançada
Ano de início
Entree


Anti-Inflammatory and Analgesic Evaluation of a Phytochemical Intercalated into Layered Double Hydroxide

Texto completo
Autor(es):
Guilherme, Viviane A. ; Cunha, Vanessa R. R. ; de Paula, Eneida ; de Araujo, Daniele R. ; Constantino, Vera R. L.
Número total de Autores: 5
Tipo de documento: Artigo Científico
Fonte: PHARMACEUTICS; v. 14, n. 5, p. 18-pg., 2022-05-01.
Resumo

Coumaric acid (CouH), an antioxidant molecule assimilated by food consumption, was intercalated into layered double hydroxide (LDH) nanocarrier, having zinc and aluminium ions in the layers (LDH-Cou), to evaluate its pharmacological activity through in vitro and in vivo assays in mice. Therefore, the following tests were performed: coumarate delivery in saline solution, fibroblasts' cell viability using neutral red, peritonitis induced by carrageenan, formalin test, acetic-acid-induced writhing, and tail-flick assay, for the non-intercalated CouH and the intercalated LDH-Cou system. Furthermore, different pharmacological pathways were also investigated to evaluate their possible anti-inflammatory and antinociceptive mechanisms of action, in comparison to traditionally used agents (morphine, naloxone, caffeine, and indomethacin). The LDH-Cou drug delivery system showed more pronounced anti-inflammatory effect than CouH but not more than that evoked by the classic non-steroidal anti-inflammatory drug (NSAID) indomethacin. For the analgesic effect, according to the tail-flick test, the treatment with LDH-Cou expressively increased the analgesia duration (p < 0.001) by approximately 1.7-1.8 times compared to CouH or indomethacin. Thus, the results pointed out that the LDH-Cou system induced in vivo analgesic and anti-inflammatory activities and possibly uses similar mechanisms to that observed for classic NSAIDs, such as indomethacin. (AU)

Processo FAPESP: 12/12209-9 - Carregadores inorgânicos de substâncias bioativas: desenvolvimento, caracterização, estudos de toxicidade, de liberação in vitro e de absorção in vivo após administração oral
Beneficiário:Vanessa Roberta Rodrigues da Cunha
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado